glioblastoma multiforme

Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Study: Novocure’s Optune, drug combo adds months to the lives of GBM patients
Drug Delivery Business News
Novocure
Optune
glioblastoma multiforme
Flag link:
Novogen irons out Phase 2 plans for brain cancer candidate
Novogen irons out Phase 2 plans for brain cancer candidate
BioPharma Dive
Novagen
clinical trials
GDC-0084
glioblastoma multiforme
brain cancer
Flag link:
Tracon Tanks on Brain Cancer Drug Failure
Tracon Tanks on Brain Cancer Drug Failure
Investopedia
TRACON Pharmaceuticals
glioblastoma multiforme
brain cancer
TRC105
Flag link:
Northwest Bio Spikes on Lifting of Clinical Hold
Northwest Bio Spikes on Lifting of Clinical Hold
Investopedia
Northwest Biotherapeutics
DCVax-L
glioblastoma multiforme
brain cancer
Flag link:
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
Celldex Brain Tumor Vaccine Fails Pivotal Clinical Trial
TheStreet.com
Celldex Therapeutics
clinical trials
Rintega
glioblastoma multiforme
Flag link:
NovoCure’s cancer therapy effective in late-stage study
NovoCure’s cancer therapy effective in late-stage study
Mass Device
Novocure
Optune
brain cancer
glioblastoma multiforme
devices
Flag link:
Celldex vaccine improves long-term brain cancer survival in study
Celldex vaccine improves long-term brain cancer survival in study
Yahoo/Reuters
Celldex
vaccines
brain cancer
glioblastoma multiforme
Rintega
Flag link:
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
ASCO Wrapup: Immunotherapy Shines, Hope For Brain Tumors, & The Great Cancer Drug Price Debate
Forbes
ASCO
cancer immunotherapy
glioblastoma multiforme
Merck
Genentech
Celldex Therapeutics
Flag link:
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
ASCO: Celldex's glioblastoma vaccine scores a clear survival benefit
Fierce Biotech
ASCO
Celldex
glioblastoma multiforme
brain cancer
Rintega
Flag link:
Novogen Makes Big Step In Fighting Brain Cancer
Novogen Makes Big Step In Fighting Brain Cancer
24/7 Wall St
Novogen
TRXE-009
glioblastoma multiforme
brain cancer
Flag link:
Celldex Therapeutics To Enter Talks With FDA
Celldex Therapeutics To Enter Talks With FDA
Seeking Alpha
Celldex Therapeutics
FDA
GBM
rindopepimut
glioblastoma multiforme
Flag link:
FDA grants orphan drug designation to potential Insys brain cancer treatment
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Insys
orphan drugs
FDA
CBD
glioblastoma multiforme
Flag link:
AbbVie makes inroads in orphan drugs
AbbVie makes inroads in orphan drugs
Medical Marketing and Media
AbbVie
orphan drugs
glioblastoma multiforme
ABT-414
Flag link:
Northwest Bio DC-Vax Study Changes Hint at Failure
Northwest Bio DC-Vax Study Changes Hint at Failure
TheStreet.com
Northwest Biotherapeutics
DCVax
vaccines
glioblastoma multiforme
Flag link:
Agenus brain cancer vaccine nearly doubles survival rate in study
Agenus brain cancer vaccine nearly doubles survival rate in study
Yahoo/Reuters
Agenus
brain cancer
vaccines
glioblastoma multiforme
Flag link:
AbbVie heralds early success with its brain cancer-fighting armed antibody
AbbVie heralds early success with its brain cancer-fighting armed antibody
Fierce Biotech
glioblastoma multiforme
ABT-414
AbbVie
Flag link:
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
Northwest Bio Warns FDA May Throw Out Phase III Brain Cancer Study
TheStreet.com
FDA
Northwest Biotherapeutics
glioblastoma multiforme
DCVax
Flag link:
Germany OKs Northwest Bio brain cancer drug, shares soar
Germany OKs Northwest Bio brain cancer drug, shares soar
Yahoo/Reuters
Germany
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
Flag link:
Panel recommends Northwest Bio brain-cancer trial continue
Panel recommends Northwest Bio brain-cancer trial continue
Yahoo/Reuters
Northwest Biotherapeutics
glioblastoma multiforme
clinical trials
DCVax-L
Flag link:
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
Northwest Bio: Interim Analysis of Brain Cancer Vaccine Study Past Due
TheStreet.com
glioblastoma multiforme
DCVax
Northwest Biotherapeutics
ICT-107
ImmunoCellular Therapeutics
Flag link:

Pages